Analysis of Adverse Drug Reaction Reports from a Public Hospital in Shanxi Province in 2022

Analysis of Adverse Drug Reaction Reports from a Public Hospital in Shanxi Province in 2022

Xiao-Jie Zhang,1 Jian-Guo Zhou,1 Miao Pan,1 Wei Yuan,2 Bo Gao1 1Department of Pharmacy, General Hospital of Yangquan Coal Industry Group, Yangquan, People’s Republic of China; 2Department of Oncology and Interventional Radiology, Yangquan Hospital of Shanxi Medical University, Yangquan, People’s Rep...

Full description

Bibliographic Details
Main Authors:	Zhang XJ, Zhou JG, Pan M, Yuan W, Gao B
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-08-01
Series:	Risk Management and Healthcare Policy
Subjects:	adverse drug reactions adverse events report analysis the rational use of drugs
Online Access:	https://www.dovepress.com/analysis-of-adverse-drug-reaction-reports-from-a-public-hospital-in-sh-peer-reviewed-fulltext-article-RMHP

Similar Items

Adverse drug reactions in psychiatry outpatient department of a tertiary care hospital in Western Uttar Pradesh: An observational study
by: Jaspreet Kaur Sidhu, et al.
Published: (2022-01-01)

Knowledge, Attitude and Perception of Pharmacovigilance Awareness among Interns at a Tertiary Care Teaching Hospital, Andhra Pradesh, India
by: G Ravindrakumar, et al.
Published: (2022-09-01)

Rational Organisation of Adverse Drug Reaction Monitoring
by: L. V. Shukil, et al.
Published: (2022-10-01)

Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania
by: Agne Valinciute-Jankauskiene, et al.
Published: (2021-03-01)

EVALUATIONS OF ADVERSE DRUGS REACTIONS IN RUSSIA IN 2013
by: V. A. Merkulov, et al.
Published: (2022-05-01)

Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017
by: H Steyn
Published: (2023-06-01)

A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024-02-01)

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
by: Francesca Filippi-Arriaga, et al.
Published: (2023-07-01)

Adverse Drug Reactions in Mazandaran Province, Iran, 2004-2018
by: Fatemeh Izadpanah, et al.
Published: (2020-05-01)

Evaluation of knowledge, attitude, and practice of adverse drug reactions reporting among doctors and nursing staff of a rural tertiary care teaching hospital of Maharashtra
by: Satish E Bahekar, et al.
Published: (2018-01-01)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023-04-01)

Pharmacovigilance in Serbia: a Ten-Year Pharmacoepidemiologic Analysis
by: Dejan Živanović, et al.
Published: (2023-01-01)

Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
by: Silvia Fernandez, et al.
Published: (2021-03-01)

Perceptions and barriers of adverse drug reaction reporting within inpatient state psychiatric facilities
by: Carolyn O'Donnell, PharmD1, et al.
Published: (2023-08-01)

Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study
by: Agne Valinciute, et al.
Published: (2023-04-01)

Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years
by: Julia E. Karrer, et al.
Published: (2019-06-01)

Spontaneous Reporting of Adverse Drug Reactions in a Pediatric Population in a Tertiary Hospital
by: Laura López-Valverde, et al.
Published: (2021-11-01)

Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database
by: Mansour Tobaiqy, et al.
Published: (2021-04-01)

Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine
by: Andrea Rodríguez-Lopez, et al.
Published: (2024-01-01)

A Standardized Dataset of a Spontaneous Adverse Event Reporting System
by: Mohammad Ali Khaleel, et al.
Published: (2022-02-01)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023-01-01)

Adverse drug reactions to first-line antituberculosis drugs at four DOTS centers in Goa, India
by: Rupchandra Navelkar, et al.
Published: (2023-01-01)

Adverse drug reaction reporting by healthcare providers in sub-Saharan Africa: A scoping review of the challenges faced and the strategies to address the challenges
by: Enos Moyo, et al.
Published: (2023-01-01)

Risk factors for adverse drug reactions associated with clopidogrel therapy
by: Mugosa Snezana, et al.
Published: (2022-04-01)

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007–2018
by: Iwona Popiołek, et al.
Published: (2019-01-01)

Prevalence of urgent hospitalizations caused by adverse drug reactions: a cross-sectional study
by: Junpei Komagamine
Published: (2024-03-01)

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
by: Skryabina A.A., et al.
Published: (2023-03-01)

Adverse-drug reaction reporting by Pharm D students during hospital training
by: Anan S. Jarab, et al.
Published: (2023-07-01)

Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients
by: Enriqueta Vallejo-Yagüe, et al.
Published: (2022-01-01)

Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis
by: Annette Haerdtlein, et al.
Published: (2023-02-01)

Assessment of risk perception of patients concerning adverse drug reactions
by: Joaquim João José, et al.
Published: (2023-06-01)

Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals’ Perspectives on How to Improve Reporting
by: Andreas Sandberg, et al.
Published: (2022-05-01)

PHARMACOEPIDEMIOLOGICAL STUDIES OF ADVERSE REACTIONS OF DEVELOPED DRUGS
by: E. J. Kolesnikova
Published: (2022-06-01)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
by: Hyeong-Geun Jo, et al.
Published: (2021-12-01)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs
by: James D. Noyes, et al.
Published: (2021-08-01)

Adverse drug events caused by medication errors in medical inpatients
by: B Hardmeier, et al.
Published: (2004-11-01)

Adverse event reporting practices in drug-resistant tuberculosis facilities across South Africa
by: Razia Gaida, et al.
Published: (2023-12-01)

An Artificial Intelligence Approach to Support Detection of Neonatal Adverse Drug Reactions Based on Severity and Probability Scores: A New Risk Score as Web-Tool
by: Nadir Yalçın, et al.
Published: (2022-11-01)

Cost Estimations of Managing Adverse Drug Reactions in Hospitalized Patients: A Systematic Review of Study Methods and Their Influences
by: Siti Fauziah Abu, et al.
Published: (2023-04-01)

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system
by: Hongli Wang, et al.
Published: (2024-01-01)